Journal of the Chinese Medical Association : JCMA
-
We previously confirmed the targeting of high-mobility group box 1 (HMGB1) by miR-25. This project aims to further investigate whether miR-25 improves myocardial ischemia-reperfusion injury (IRI) in vivo by targeting HMGB1. ⋯ MiR-25 mitigated myocardial IRI-induced damage by targeting HMGB1.